Treatment of age-related neovascular macular degeneration: the patient’s perspective

被引：0
|
作者：
S. Müller
C. Ehlken
U. Bauer-Steinhusen
W. Lechtenfeld
Z. Hasanbasic
H. Agostini
T. Wilke
机构：
[1] University of Wismar,IPAM
[2] Universitäts-Klinikum Schleswig-Holstein, Institute for Pharmacoeconomics and Medication Logistics
[3] Medical Affairs,Department of Ophthalmology
[4] PRO RETINA Deutschland e.V,Bayer Vital GmbH
[5] University of Freiburg,Eye Center, Medical Center, Faculty of Medicine
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2017年 / 255卷
关键词：
Neovascular age-related macular degeneration; Anti-VEGF therapy; Patient perspective; Prospective non-interventional cohort study; Germany;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2237 / 2246
页数：9
相关论文
共 50 条
  • [21] Treatment of neovascular age-related macular degeneration in patients with diabetes
    Cummings, Michael
    Cunha-Vaz, Jose
    [J]. CLINICAL OPHTHALMOLOGY, 2008, 2 (02): : 369 - 375
  • [22] Pegaptanib Sodium in the Treatment of Neovascular Age-Related Macular Degeneration
    Querques, Giuseppe
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 225 - 234
  • [23] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    [J]. OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [24] Treatment of neovascular age-related macular degeneration: Current therapies
    Augustin, Albert J.
    Scholl, Stefan
    Kirchhof, Janna
    [J]. CLINICAL OPHTHALMOLOGY, 2009, 3 : 175 - 182
  • [25] VEGF inhibitors for the treatment of neovascular age-related macular degeneration
    Barakat, Mark Rami
    Kaiser, P. K.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (05) : 637 - 646
  • [26] Combination therapy for the treatment of neovascular age-related macular degeneration
    Englander, Miriam
    Kaiser, Peter K.
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2013, 24 (03) : 233 - 238
  • [27] Pegaptanib sodium for the treatment of neovascular age-related macular degeneration
    Moshfeghi, AA
    Puliafito, CA
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (05) : 671 - 682
  • [28] Review of Neovascular Age-Related Macular Degeneration Treatment Options
    Holekamp, Nancy M.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (07): : S172 - S181
  • [29] Personalized Approach in Treatment of Neovascular Age-Related Macular Degeneration
    Kirkova, Radina
    Murgova, Snezhana
    Kirkov, Vidin
    Tanev, Ivan
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
  • [30] PATIENT PREFERENCES IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A DISCRETE CHOICE EXPERIMENT
    Mueller, S.
    Ehlken, C.
    Agostini, H.
    Bauer-Steinhusen, U.
    Hasanbasic, Z.
    Wilke, T.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A571 - A572
12345